🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objectives: * To evaluate the safety and tolerability of isatuxima...
Status
Completed
Location
~Banner MD Anderson Cancer Center Site Number : 8400005
Start Date
2019-08-06
Trial ID
NCT04045795
The primary purpose of this study is to assess the efficacy (overall respon...
Status
Recruiting
Location
Mayo Clinic in Arizona - Phoenix- Site Number : 8400058
Start Date
2025-03-17
Trial ID
NCT06356571
The purpose of this clinical trial is to learn how the experimental medicin...
Status
Terminated
Location
Keck Hospital of USC
Start Date
2018-05-14
Trial ID
NCT03530683
The primary objective of this Phase Ib/II trial is to study the safety and ...
Status
Recruiting
Location
University of Wisconsin
Start Date
2026-07
Trial ID
NCT07479979
Treatments Being Tested
This study is to evaluate the combination of isatuximab, iberdomide, bortez...
Status
Not Yet Recruiting
Location
Beth Israel Deaconess Medical Center (BIDMC)
Start Date
2026-06-26
Trial ID
NCT07601100
Treatments Being Tested
The goal of this clinical trial is to learn if anitocabtagene autoleucel fo...
Status
Recruiting
Location
Hospital Germans Trias i Pujol (ICO BADALONA)
Start Date
2025-06-30
Trial ID
NCT07045909
This research study is investigating the safety and effectiveness of using ...
Status
Recruiting
Location
University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center
Start Date
2022-02-18
Trial ID
NCT05145400
Treatments Being Tested
Primary Objectives: * Part A: To evaluate the safety and tolerability of s...
Status
Terminated
Location
Fox Chase Cancer Center Site Number : 8400004
Start Date
2021-09-09
Trial ID
NCT04661033
Treatments Being Tested
This is a randomized, multicenter, Phase 3, open-label study evaluating sub...
Status
Active Not Recruiting
Location
Mohtaseb Cancer Center and Blood Disorders Site Number : 8400028
Start Date
2022-06-23
Trial ID
NCT05405166
This phase I trial studies the side effects of isatuximab and to see how we...
Status
Active Not Recruiting
Location
University of California
Start Date
2021-04-28
Trial ID
NCT04754945
Treatments Being Tested